http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060129276-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 |
| filingDate | 2005-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0480978f2908a98ac953e238497a4b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebbf482521f36e2c6919a7433ac5b45a |
| publicationDate | 2006-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20060129276-A |
| titleOfInvention | Thiazole derivatives as a2b antagonists |
| abstract | The present invention provides compounds of formula I in free or salt form:n n n <Formula I>n n n n n n n n Wheren n n Ar is phenyl substituted with one or more substituents selected from halogen, cyano and C 1 -C 8 -haloalkyl, or naphthyl,n n n R 1 is hydrogen or halogen, cyano, hydroxy, C 1 -C 8 -alkyl, C 1 -C 8 -haloalkyl, C 1 -C 8 -alkoxy, C 1 -C 8 -alkoxy-C 1 Phenyl optionally substituted by one or more substituents selected from -C 8 -alkyl, carboxy, C 1 -C 8 -alkoxycarbonyl and acyloxy, or R 1 is a 5- or 6-membered monovalent heterocyclic group ego,n n n R 2 is hydrogen, C 1 -C 8 -alkyl, acyl or —CON (R 3 ) R 4 ,n n n R 3 and R 4 are each independently hydrogen or C 1 -C 8 -alkyl, or together with the nitrogen atom to which they are attached represent a 5- or 6-membered heterocyclic group,n n n Y is one or more C 1 -C 8 - alkyl, C 1 -C 8 - alkoxy, C 1 -C 8 - alkylthio, C 1 -C 8 - alkyl group, a di (C 1 -C 8 - alkyl, ) Pyrimidinyl group or pyridazinyl group optionally substituted with an amino group or an acylamino group.n n n The compound is useful as a medicament. |
| priorityDate | 2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 319.